Steven Aronin is an Infectious Disease physician. OpenAlex indexes 56 publications with 1,270 citations (h-index 15); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
140 Grandview Ave
Suite L01
Waterbury, CT 067082505
Telephone
203-574-4187Registry record last updated 8 Jul 2007.
Clinical trials
- Safety, Tolerability, and Pharmacokinetics of Sulopenem in Adolescents
Sponsor: Iterum Therapeutics, International Limited
- Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)
Sponsor: Iterum Therapeutics, International Limited
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ViiV Healthcare CompanyProgram year20242 payments
- ViiV Healthcare CompanyProgram year20234 payments
- ViiV Healthcare CompanyProgram year20223 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
70.8%Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor26%Dovato52%Juluca48%Part D<11 patientsHuman Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor15.6%Efavirenz-Emtric-Tenofov Disop100%Part D<11 patients+ 2 more classes in this area
Nervous system
15.6%Gabapentinoids15.6%Gabapentin100%Part D<11 patientsGenitourinary & hormones
13.5%Progestin13.5%Megestrol Acetate100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- <i>In vitro</i> activity and <i>in vivo</i> efficacy of sulopenem against <i>Bacillus anthracis</i> in inhalational anthrax mouse and rabbit models
Antimicrobial Agents and Chemotherapy
2026 - P-784. Risk Factors for Treatment Failure in Patients with Uncomplicated Urinary Tract Infection
Open Forum Infectious Diseases
2026 - In vitro activity of sulopenem and comparator agents against US Enterobacterales clinical isolates collected during the SENTRY antimicrobial surveillance program in 2023
Journal of Global Antimicrobial Resistance
2025
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Myron Cohen, MD
University of North Carolina at Chapel Hill School of Medicine
Derrick W. Crook
John Radcliffe Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”